Levalbuterol Solution
Product Images NDC 81894-101

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Levalbuterol (NDC 81894-101). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Luoxin Aurovitas Pharma (chengdu) Co., Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Levalbuterol Fig1)

FDA Label Image

Figure F.1, F.2 (Levalbuterol Fig10)

FDA Label Image

Levalbuterol-pouch-0.31mg (Levalbuterol Fig11)

FDA Label Image

Levalbuterol-carton-0.31 (Levalbuterol Fig12)

This is a description of Levalbuterol Inhalation Solution, USP in 0.31 mg/3 mL strength, packaged in sterile unit-dose vials. Each vial contains 0.31 mg of levalbuterol (equivalent to levalbuterol hydrochloride USP 0.36 mg) and is designed for oral inhalation only. The solution does not contain preservatives and should be used as directed by a physician, with dosage not to be exceeded. The product should be protected from light and stored at 20° to 25°C. Unit-dose vials need to be stored in the provided foil pouch, and once opened, vials are recommended to be used within two weeks. The manufacturer is Aurobindo Pharma USA, Inc., distributed in the US.*

FDA Label Image

Levalbuterol-pouch-0.63mg (Levalbuterol Fig13)

FDA Label Image

Levalbuterol-carton-0.63 (Levalbuterol Fig14)

This is a description of a pharmaceutical product - Levalbuterol Inhalation Solution in 3 mL unit-dose vials. Each vial contains 0.63 mg of levalbuterol. The solution is for oral inhalation only and does not contain preservatives. It is recommended to store the vials in the protective foil pouch and discard if the solution is not colorless. The product should be used within two weeks after opening the foil pouch and within one week after removing the vial from the pouch. This medication is distributed by Aurobindo Pharma USA, Inc. and manufactured in Chengdu, China. It should be used as directed by a physician and kept out of reach of children.*

FDA Label Image

Levalbuterol-pouch-1.25mg (Levalbuterol Fig15)

This text provides detailed information about a medication called Levalbuterol Inhalation Solution, USP, which comes in unit-dose vials containing 1.25 mg of levalbuterol. It includes instructions for storage, handling, and usage, as well as precautions for pharmacists and patients. The medication does not contain preservatives and is meant for oral inhalation only. It is manufactured by Aurobindo Pharma USA, Inc. and Luoxin Aurovitas Pharma in China.*

FDA Label Image

Levalbuterol-carton-1.25mg (Levalbuterol Fig16)

This text describes a medication called Levalbuterol Inhalation Solution, USP, which is available in unit-dose vials containing 1.25 mg of levalbuterol. The solution is for oral inhalation only and each vial should be used within the specified timeframe after opening. The solution contains no preservatives and should be stored as per the given instructions. The manufacturer is Aurobindo Pharma and the product is distributed in the USA. The text includes details on potency, storage, manufacturer's information, and guidelines for pharmacists and patients.*

FDA Label Image

Figure 2 (Levalbuterol Fig2)

This text provides data on the mean percent change from baseline Forced Expiratory Volume (FEV) on Day 29 for adults and adolescents over 12 years old. It includes information for different treatments (Lev1.25, Lev 063, Rac 25, and PBO) with sample sizes for each group. Additionally, the text shows a 15% mean change in FEV over time.*

FDA Label Image

Figure 3 (Levalbuterol Fig3)

FDA Label Image

Figure 4 (Levalbuterol Fig4)

FDA Label Image

Figure A (Levalbuterol Fig5)

FDA Label Image

Figure B (Levalbuterol Fig6)

FDA Label Image

Figure C (Levalbuterol Fig7)

FDA Label Image

Figure D.1, D.2 (Levalbuterol Fig8)

FDA Label Image

Figure E (Levalbuterol Fig9)

FDA Label Image

Levalbuterol Hydrochloride Chemical Structure (Levalbuterol Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.